Orion is a Finnish pharmaceutical company that operates globally. Orion develops, manufactures and markets human and veterinary drugs and active pharmaceutical ingredients. The company is continuously investing in researching and developing new medicines and treatments.
The core therapy areas of Orion’s pharmaceutical research are central nervous system diseases, cancer, and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.
Orion’s clientele consists mainly of healthcare and healthcare service providers and professionals. Customers include specialist and general practitioners, veterinarians, pharmacies, hospitals, health centres, medical centres and laboratories. Consumers and pets are also an important customer group.
Orion’s main market area is in Finland, where the company is a clear market leader. Orion’s products are on the market in more than 100 countries, and the Group’s own human pharmaceutical sales organization covers almost all major European markets. In other areas, Orion’s products are sold by several partners. All Orion factories and the majority of R & D activities are located in Finland. The company is headquartered in Espoo, Finland.
Stephan Van Nieuwenhove of Finnish national champion Orion Pharma outlines the company’s entrance into the Benelux markets, the significance of the recent acquisition of Belgian animal health firm Inovet BV,…
Starting as a one-man-show when he began the Greek affiliate in 2009, Orion Pharma’s General Manager, Thanassis Panopoulos discusses the company’s high level of resiliency, the challenges of bringing a…
Bernardo de Rafael Topfer, Iberia Country Manager, speaks about how middle-sized companies like Orion can use niche indications to their advantage in the face of strong competition from big pharma’s…
Orion’s global strategy focuses on the CIS and Eastern European markets that still exhibit large growth potential and are expanding, despite a reverse trend for the rest of the industry.…
Starting as a one-man-show when he began the Greek affiliate in 2009, Orion Pharma’s General Manager, Thanassis Panopoulos discusses the company’s high level of resiliency, the challenges of bringing a…
See our Cookie Privacy Policy Here
